Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
Mepolizumab Long-term Access Programme for Subjects Who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis in Subjects Receiving Standard-of-care Therapy) Mepolizumab Long-term Access Programme for Subjects Who Participated in Study MEA115921 (Placebo-con ...